Lipegfilgrastim
Lipegfilgrastim
Lipegfilgrastim (pronounced as li-peg-fil-gras-tim) is a biopharmaceutical drug used for the treatment of neutropenia, a condition characterized by an abnormally low count of neutrophils, a type of white blood cell that helps fight off infections.
Etymology
The term "Lipegfilgrastim" is derived from the combination of "pegfilgrastim", a similar drug, and "li-", a prefix used in pharmacology to denote a lipid or fat molecule. The "peg" in pegfilgrastim stands for polyethylene glycol, a compound used to increase the drug's half-life in the body.
Usage
Lipegfilgrastim is used to prevent neutropenia, which can be a side effect of chemotherapy. It stimulates the bone marrow to produce more neutrophils, thereby reducing the risk of infection in patients undergoing chemotherapy.
Related Terms
- Neutropenia: A condition characterized by an abnormally low count of neutrophils.
- Neutrophils: A type of white blood cell that helps fight off infections.
- Chemotherapy: A type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen.
- Biopharmaceutical: A type of medicinal drug product manufactured in, extracted from, or semi synthesized from biological sources.
- Polyethylene glycol: A polyether compound used in a variety of fields including pharmaceuticals.
See Also
External links
- Medical encyclopedia article on Lipegfilgrastim
- Wikipedia's article - Lipegfilgrastim
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski